BioCentury
ARTICLE | Clinical News

FDA panel backs Siga's antiviral for smallpox

May 4, 2018 6:50 PM UTC

Siga Technologies Inc. (NASDAQ:SIGA) said FDA's Antimicrobial Drugs Advisory Committee voted 17-0 on May 1 that the benefit-risk profile of oral TPOXX tecovirimat (oral ST-246) supports its use to treat smallpox infection. The candidate's PDUFA date is Aug. 8...

BCIQ Company Profiles

Siga Technologies Inc.